Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
D L Kaufman(University of California, Los Angeles), Allan J. Tobin(Allen Institute for Brain Science), Mark G. Erlander(University of California, Los Angeles), Michael Clare‐Salzler(Montreal Neurological Institute and Hospital), Mark A. Atkinson(University of Florida), Noel K. Maclaren(University of Florida)
Cited by 492
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k